NCT00225784View on ClinicalTrials.gov

Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

February 28, 2010

Study Completion Date

September 30, 2012

Conditions
Pancreatic Cancer
Interventions
DRUG

Cetuximab/Gemcitabine

Once weekly Cetuximab, twice weekly Gemcitabine for six weeks

PROCEDURE

Radiotherapy

Daily radiotherapy for 28 days

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT00225784 - Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer | Biotech Hunter | Biotech Hunter